ReviewJournal of the American Society for Mass Spectrometry2026
Mass Spectrometry-Based Proteomics Methods for Systematic Identification and Quantification of Protein O-Glycosylation in Complex Biological Samples.
Review in Journal of the American Society for Mass Spectrometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Protein O-glycosylation is one of the most common and important modifications in human cells. It regulates protein folding, trafficking, stability, and interactions with other molecules, and its dysregulation is directly related to numerous diseases such as cancer and neurodegenerative diseases. Modern mass spectrometry (MS)-based proteomics provides a unique opportunity to systematically characterize O-glycosylated proteins. However, it is still extremely challenging due to the low abundance of many glycoproteins, the heterogeneity of O-glycans, and the complexity of biological samples. In this review, we discuss recent advances in MS-based proteomics methods designed to overcome the challenges for global and site-specific characterization of protein O-glycosylation. We begin with an overview of the biosynthetic pathways underlying the major classes of protein O-glycosylation. Then, we discuss different methods to enrich O-glycopeptides with diverse structures of O-glycans. Furthermore, various MS dissociation techniques for intact glycopeptide profiling are covered. In addition, different quantitative approaches are included for studying protein O-glycosylation in biological and biomedical research. We also discuss computational tools for intact O-glycopeptide identification, highlighting the challenges in search space requirement, false discovery rate control, and glycosylation site localization. The advancements of MS-based glycoproteomics are critical for gaining insights into the critical roles of protein O-glycosylation in biology and human disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.